Charles Schwab’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-41,972
Closed -$15.5K 3652
2023
Q2
$15.5K Sell
41,972
-244,838
-85% -$209K ﹤0.01% 3582
2023
Q1
$522K Buy
286,810
+2,353
+0.8% +$5.11K ﹤0.01% 2932
2022
Q4
$589K Sell
284,457
-9
-0% -$28 ﹤0.01% 2949
2022
Q3
$857K Buy
284,466
+47,697
+20% +$169K ﹤0.01% 2835
2022
Q2
$758K Buy
236,769
+205,129
+648% +$1.11M ﹤0.01% 2901
2022
Q1
$205K Buy
31,640
+77
+0.2% +$697 ﹤0.01% 3302
2021
Q4
$424K Buy
+31,563
New +$347K ﹤0.01% 3198

Other funds holding HLTH

Charles Schwab's HLTH Position: Q3 2023 in Review

Charles Schwab sold out of Cue Health Inc. Common Stock (HLTH) in Q3 2023, closing a stake of 41,972 shares — an estimated $15.5K sold.

Charles Schwab first reported a position in HLTH in Q4 2021 and held it in 7 quarters. The position peaked at $857K in Q3 2022. 72 funds tracked by Wall St. Rank hold HLTH as of Q3 2023.

  • Charles Schwab reported no remaining Cue Health Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Charles Schwab sold 41,972 Cue Health Inc. Common Stock shares in Q3 2023, an estimated $15.5K.
  • Charles Schwab first reported a position in Cue Health Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • Charles Schwab's Cue Health Inc. Common Stock position peaked at $857K in Q3 2022.
  • 72 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q3 2023.

Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.